First Washington Corp’s Bristol-Myers Squibb BMY Stock Holding History

First Washington Corp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,500	Closed	-$94K	–	63
2021 Q4	$94K	Hold	1,500	–	–	0.04%	69
2021 Q3	$89K	Hold	1,500	–	–	0.03%	72
2021 Q2	$100K	Hold	1,500	–	–	0.04%	69
2021 Q1	$95K	Hold	1,500	–	–	0.04%	72
2020 Q4	$93K	Hold	1,500	–	–	0.04%	60
2020 Q3	$90K	Hold	1,500	–	–	0.05%	60
2020 Q2	$88K	Hold	1,500	–	–	0.05%	62
2020 Q1	$84K	Hold	1,500	–	–	0.05%	59
2019 Q4	$96K	Buy	+1,500	New	+$85.9K	0.04%	59

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

First Washington Corp's BMY Position: Q1 2022 in Review

First Washington Corp sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 1,500 shares — an estimated $94K sold.

First Washington Corp first reported a position in BMY in Q4 2019 and held it in 9 quarters. The position peaked at $100K in Q2 2021. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

First Washington Corp reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
First Washington Corp sold 1,500 Bristol-Myers Squibb shares in Q1 2022, an estimated $94K.
First Washington Corp first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 9 quarters.
First Washington Corp's Bristol-Myers Squibb position peaked at $100K in Q2 2021.
2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on First Washington Corp's 13F filing for Q1 2022, filed 11 May 2022.